Middle Meningeal Artery Embolization for Chronic Subdural Hematoma

Overview

Journal Front Neurol

Specialty Neurology

Date 2020 Nov 16

PMID 33192990

Citations 23

Authors

Joshua S Catapano

Candice L Nguyen

Andre A Wakim

Felipe C Albuquerque

Andrew F Ducruet

Affiliations

Soon will be listed here.

Abstract

Chronic subdural hematoma (cSDH) is a common disease process associated with significant morbidity that occurs most often in elderly patients. Asymptomatic patients are typically treated conservatively, with surgical intervention reserved for patients with symptomatic and/or large hematomas that cause brain compression. However, conservatively managed cSDH cases frequently progress, and surgical evacuation of cSDH is associated with high rates of complication and recurrence. Recently, successful treatment of cSDH via middle meningeal artery (MMA) embolization has been reported in small case series and case reports. This article reviews the existing literature on MMA embolization for cSDH and discusses the need for randomized control trials and/or large prospective studies to establish the efficacy of MMA embolization for this disease.

Citing Articles

Effectiveness of a single burr hole as a surgical technique for the management of chronic subdural hematoma: A clinical case series study.

Fotakopoulos G, Gatos C, Georgakopoulou V, Spandidos D, Trakas N, Sklapani P Exp Ther Med. 2024; 29(1):19.

PMID: 39624590 PMC: 11609760. DOI: 10.3892/etm.2024.12769.

Preservation of the middle meningeal artery during unruptured aneurysm surgery: an independent risk factor for postoperative chronic subdural hematoma.

Kim M Front Neurol. 2024; 15:1400788.

PMID: 38770526 PMC: 11103014. DOI: 10.3389/fneur.2024.1400788.

Middle Meningeal Artery Embolization in Acute Leukemia Patients Presenting With Subdural Hematoma.

Yohannan B, Gutierrez J, Chen P, Rios A J Hematol. 2024; 13(1-2):39-45.

PMID: 38644984 PMC: 11027772. DOI: 10.14740/jh1215.

Spontaneous Intracranial Hypotension and Subdural Hematomas Treatment Management Using MMA Embolization and Target Blood Patch: A Case Report.

Cirillo L, Verna F, Princiotta C, DallOlio M, Rustici A, Bortolotti C Life (Basel). 2024; 14(2).

PMID: 38398759 PMC: 10890540. DOI: 10.3390/life14020250.

Predicting the progression of chronic subdural hematoma based on skull density.

Yang W, Chen Q, Yao H, Zhang J, Zhang Q, Fang J Front Neurol. 2023; 14:1279292.

PMID: 37928152 PMC: 10623350. DOI: 10.3389/fneur.2023.1279292.

References

Link T, Rapoport B, Paine S, Kamel H, Knopman J . Middle meningeal artery embolization for chronic subdural hematoma: Endovascular technique and radiographic findings. Interv Neuroradiol. 2018; 24(4):455-462. PMC: 6050895. DOI: 10.1177/1591019918769336. View

Rudiger A, Ronsdorf A, Merlo A, Zimmerli W . Dexamethasone treatment of a patient with large bilateral chronic subdural haematomata. Swiss Med Wkly. 2001; 131(25-26):387. DOI: 10.4414/smw.2001.09745. View

Thotakura A, Marabathina N . Nonsurgical Treatment of Chronic Subdural Hematoma with Steroids. World Neurosurg. 2015; 84(6):1968-72. DOI: 10.1016/j.wneu.2015.08.044. View

Kim E . Embolization Therapy for Refractory Hemorrhage in Patients with Chronic Subdural Hematomas. World Neurosurg. 2017; 101:520-527. DOI: 10.1016/j.wneu.2017.02.070. View

Thotakura A, Marabathina N . The Role of Medical Treatment in Chronic Subdural Hematoma. Asian J Neurosurg. 2018; 13(4):976-983. PMC: 6208261. DOI: 10.4103/ajns.AJNS_13_17. View

Foelholm R, WALTIMO O . Epidemiology of chronic subdural haematoma. Acta Neurochir (Wien). 1975; 32(3-4):247-50. DOI: 10.1007/BF01405457. View

Takizawa K, Sorimachi T, Ishizaka H, Osada T, Srivatanakul K, Momose H . Enlargement of the middle meningeal artery on MR angiography in chronic subdural hematoma. J Neurosurg. 2015; 124(6):1679-83. DOI: 10.3171/2015.5.JNS1567. View

Matsumoto H, Hanayama H, Okada T, Sakurai Y, Minami H, Masuda A . Which surgical procedure is effective for refractory chronic subdural hematoma? Analysis of our surgical procedures and literature review. J Clin Neurosci. 2017; 49:40-47. DOI: 10.1016/j.jocn.2017.11.009. View

Buttmann M, Lorenz A, Weishaupt A, Rieckmann P . Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration. J Neurochem. 2007; 102(4):1001-8. DOI: 10.1111/j.1471-4159.2007.04563.x. View

10.

Nagahori T, Nishijima M, Takaku A . [Histological study of the outer membrane of chronic subdural hematoma: possible mechanism for expansion of hematoma cavity]. No Shinkei Geka. 1993; 21(8):697-701. View

11.

Ishihara H, Ishihara S, Kohyama S, Yamane F, Ogawa M, Sato A . Experience in endovascular treatment of recurrent chronic subdural hematoma. Interv Neuroradiol. 2010; 13 Suppl 1:141-4. PMC: 3345458. DOI: 10.1177/15910199070130S121. View

12.

Fiorella D, Arthur A . Middle meningeal artery embolization for the management of chronic subdural hematoma. J Neurointerv Surg. 2019; 11(9):912-915. DOI: 10.1136/neurintsurg-2019-014730. View

13.

Kang J, Whang K, Hong S, Pyen J, Cho S, Kim J . Middle Meningeal Artery Embolization in Recurrent Chronic Subdural Hematoma Combined with Arachnoid Cyst. Korean J Neurotrauma. 2016; 11(2):187-90. PMC: 4847502. DOI: 10.13004/kjnt.2015.11.2.187. View

14.

Ng S, Derraz I, Boetto J, Dargazanli C, Poulen G, Gascou G . Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption. J Neurointerv Surg. 2019; 12(7):695-699. DOI: 10.1136/neurintsurg-2019-015421. View

15.

Allison A, Edlmann E, Kolias A, Davis-Wilkie C, Mee H, Thelin E . Statistical analysis plan for the Dex-CSDH trial: a randomised, double-blind, placebo-controlled trial of a 2-week course of dexamethasone for adult patients with a symptomatic chronic subdural haematoma. Trials. 2019; 20(1):698. PMC: 6905057. DOI: 10.1186/s13063-019-3866-6. View

16.

Jiang R, Zhao S, Wang R, Feng H, Zhang J, Li X . Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized ClinicalTrial. JAMA Neurol. 2018; 75(11):1338-1346. PMC: 6248109. DOI: 10.1001/jamaneurol.2018.2030. View

17.

Kolias A, Edlmann E, Thelin E, Bulters D, Holton P, Suttner N . Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial. Trials. 2018; 19(1):670. PMC: 6280536. DOI: 10.1186/s13063-018-3050-4. View

18.

Decaux O, Cador B, Dufour T, Jego P, Cazalets C, Laurat E . [Nonsurgical treatment of chronic subdural hematoma with steroids: two case reports]. Rev Med Interne. 2002; 23(9):788-91. DOI: 10.1016/s0248-8663(02)00676-8. View

19.

Tanaka T, Kaimori M . [Histological study of vascular structure between the dura mater and the outer membrane in chronic subdural hematoma in an adult]. No Shinkei Geka. 1999; 27(5):431-6. View

20.

Kolias A, Chari A, Santarius T, Hutchinson P . Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol. 2014; 10(10):570-8. DOI: 10.1038/nrneurol.2014.163. View